SAVIMS

SAVIMS logo white
Menu

Vaccines

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Serious Adverse Events of Special Interest Following mRNA COVID-19 Vaccination in Randomised Trials

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022). Serious adverse events of special interest following mRNA COVID-19 vaccination in randomised trials in adults. Vaccine, 40(5), 649-659. https://doi.org/10.1016/j.vaccine.2022.08.036 Summary: This article assesses serious adverse events (SAEs) associated with mRNA COVID-19 vaccines (Pfizer and Moderna) through a […]

COVID-19, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Serious Adverse Events Following mRNA COVID-19 Vaccination: An Analysis of Randomised Trials

| | COVID-19, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Fraiman, J., Erviti, J., Jones, M., Greenland, S., Whelan, P., Kaplan, R. M., & Doshi, P. (2022). Serious adverse events of special interest following mRNA COVID-19 vaccination in randomised trials in adults. Vaccine, 40(1), 1-9. https://doi.org/10.1016/j.vaccine.2022.08.036 Summary: This article examines the serious adverse events (SAEs) associated with mRNA COVID-19 vaccines (Pfizer and Moderna) as

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Evaluation of BNT162b2 Vaccine for Children Aged 5-11 in South Africa

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: South African National Department of Health. (2022). Rapid review report for COVID-19 vaccine 5–11-year-old children: Should the BNT162b2 COVID-19 vaccine be used for children aged 5 -11 years old in South Africa. Summary: A rapid review evaluated the efficacy and safety of the BNT162b2 COVID-19 vaccine for children aged 5-11 in South Africa. The

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Statistical evidence, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Criminal Claim Filed Against Swissmedic Regarding mRNA Vaccines

| | COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Statistical evidence, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Kruse, P. (2022). Swissmedic criminal claim – Executive summary. K R U S E | L A W. Retrieved from https://coronacomplaint.ch/ Summary: The article details a criminal claim involving 37 complainants and six private claimants against Swissmedic regarding the mRNA vaccines. It asserts that the administration of these vaccines poses a significant health risk,

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Cumulative and interval summary of adverse reactions (Pfizer – 2022)

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Pfizer. (2022). Cumulative and interval summary tabulation of serious and non-serious adverse reactions from post-marketing data sources BNT162B2. Summary: The document presents a comprehensive analysis of cumulative and interval data on serious and non-serious adverse reactions associated with the BNT162B2 vaccine up to June 18, 2022. It details a total of 1,485,027 cases cumulatively,

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

SA VAERS: Empowering Voices on Vaccine Adverse Events

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Unknown. (2022). SA VAERS: An independent alternative vaccine adverse events reporting system. Retrieved from https://savaers.co.za/ Summary: SA VAERS is an independent vaccine adverse events reporting system aimed at providing a platform for survivors and victims of negative effects from the COVID-19 vaccine. Managed by Transformative Health Justice, the system focuses on enhancing data transparency

COVID-19, Covid-19 vaccines, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Vaccines, Viral illnesses

Management of Post-Vaccine Syndrome: I-RECOVER Protocol

| | COVID-19, Covid-19 vaccines, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Vaccines, Viral illnesses

Reference: Marik, P. E., Kory, P., & Contributors. (2022). I-RECOVER: Post-Vaccine Treatment protocol (5/25/2022). An Approach to the Management of Post-Vaccine Syndrome. Summary: The I-RECOVER protocol is designed to aid healthcare professionals in managing patients with post-vaccine syndrome, a condition arising from COVID-19 vaccinations. While no formal definition exists, symptoms correlating temporally with vaccination can

COVID-19, Covid-19 vaccines, Ivermectin, Other scientific evidence, Treatment, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

I-RECOVER: Post-Vaccine Treatment Protocol Overview

| | COVID-19, Covid-19 vaccines, Ivermectin, Other scientific evidence, Treatment, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Kory, P., Marik, P., et al. (2022). I-RECOVER: Post-Vaccine Treatment protocol. Summary: The I-RECOVER protocol offers guidance for healthcare professionals treating patients experiencing post-vaccine syndrome, a condition with symptoms emerging or worsening following COVID-19 vaccination. Contributors, including prominent physicians, acknowledge the lack of formal recognition and classification for this syndrome by major health organisations,

COVID-19, Covid-19 vaccines, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccines, Viral illnesses

BMJ’s Concerns on Facebook’s Fact-Checking Practices

| | COVID-19, Covid-19 vaccines, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccines, Viral illnesses

Reference: Godlee, F., & Abbasi, K. (2022). Open letter from BMJ to Facebook about inappropriate censoring of serious data integrity issues in Pfizer’s COVID-19 vaccine trial. Retrieved from https://www.scientificfreedom.dk/2021/12/18/open-letter-from-bmj-to-facebook-about-inappropriate-censoring-of-serious-data-integrity-issues-in-pf Summary: In an open letter to Mark Zuckerberg, editors Fiona Godlee and Kamran Abbasi of The BMJ express grave concerns regarding Facebook’s fact-checking practices, particularly in

Scroll to Top